This paper is only available as a PDF. To read, Please Download here.
Abstract
It has been hypothesized that an alteration in the sex hormone milieu may underlie coronary heart disease (CHD) and its risk factors. Leading to this hypothesis and important to it was the observation that serum testosterone level correlated negatively and the estradiol to testosterone ratio (![Math Eq]()
) correlated positively with serum insulin and glucose levels in non-obese men. As a test of the validity of this observation, the present study was conducted to investigate these correlations in men with obesity. Obesity in men is associated with hyperestrogenemia, hypotestosteronemia, hyperinsulinemia, hyperglycemia, and CHD. To determine whether the relationships between sex hormone levels and insulin and glucose levels found in non-obese men also occur in obese men independent of obesity, fasting levels of these substances, as well as free testosterone (FT) and sex-hormone-binding globulin (SHBG), were measured in 55 obese men aged 21 to 70. Correlation coefficients of sex hormones with other risk factors for CHD, ie, cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), blood pressure, and waist to hip circumference ratio (![Math Eq]()
), were also calculated. As found previously, testosterone level correlated negatively with insulin (r = −.31, P = .01) and glucose (r = −.23, P < .05) levels and the insulin to glucose ratio (![Math Eq]()
), and ![Math Eq]()
correlated positively with insulin (r = .41, P = .001) and glucose (r = .24, P < .05) levels and ![Math Eq]()
(r = .37, P < .005). The above correlations were controlled for body mass index (BMI) and age. Many other correlations were observed. These findings support the hypothesis that an elevation of ![Math Eq]()
, or some closely related hormonal alteration, in men underlies the glucose-insulin-lipid defect associated with CHD.
) correlated positively with serum insulin and glucose levels in non-obese men. As a test of the validity of this observation, the present study was conducted to investigate these correlations in men with obesity. Obesity in men is associated with hyperestrogenemia, hypotestosteronemia, hyperinsulinemia, hyperglycemia, and CHD. To determine whether the relationships between sex hormone levels and insulin and glucose levels found in non-obese men also occur in obese men independent of obesity, fasting levels of these substances, as well as free testosterone (FT) and sex-hormone-binding globulin (SHBG), were measured in 55 obese men aged 21 to 70. Correlation coefficients of sex hormones with other risk factors for CHD, ie, cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), blood pressure, and waist to hip circumference ratio (
), were also calculated. As found previously, testosterone level correlated negatively with insulin (r = −.31, P = .01) and glucose (r = −.23, P < .05) levels and the insulin to glucose ratio (
), and 
correlated positively with insulin (r = .41, P = .001) and glucose (r = .24, P < .05) levels and 
(r = .37, P < .005). The above correlations were controlled for body mass index (BMI) and age. Many other correlations were observed. These findings support the hypothesis that an elevation of 
, or some closely related hormonal alteration, in men underlies the glucose-insulin-lipid defect associated with CHD.References
- Humoral changes in arteriosclerosis. Investigations on lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood.Lancet. 1960; 2: 1409-1416
- Carbohydrate metabolism in atherosclerosis.Metabolism. 1960; 9: 800-806
- Plasma-insulin concentrations after myocardial infarction.Lancet. 1965; 1: 1144-1145
- Plasma-insulin in coronary heart disease. Response to oral and intravenous glucose and tolbutamide.Lancet. 1965; 2: 508-511
- Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction.in: ed 2. Proc Natl Acad Sci USA. 74. 1977: 1729-1733
- Serum-insulin in essential hypertension and in peripheral vascular disease.Lancet. 1966; 1: 1336-1337
- Sex hormones, risk factors and cardiovascular disease.Am J Med. 1978; 65: 7-11
- Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort.Am J Med. 1983; 74: 863-869
- Ostrogen als Risikofaktor fur das Gefasssystem.Dtsch Med Wochenschr. 1980; 105: 1601-1603
- Endogenous sex hormones and cardiovascular disease in men.Circulation. 1988; 78: 539-545
- Sex hormone levels in young Indian patients with myocardial infarction.Arteriosclerosis. 1986; 6: 418-421
- Sex hormones, insulin, lipids and prevalent ischemic heart disease.Am J Epidemiol. 1987; 126: 647-657
- Effect of obesity and body fat distribution on sex hormones and insulin in men.Metabolism. 1991; 40: 101-104
- Gonadal dysfunction in diabetic men with organic impotence.J Clin Endocrinol Metab. 1987; 65: 127-135
- Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.Metabolism. 1990; 39: 897-901
- Relation of weight change to changes in atherogenic traits. The Framingham Study.J Chronic Dis. 1974; 27: 103-114
- Increased estrogen production in obese men.J Clin Endocrinol Metab. 1979; 48: 633-638
- Low serum testosterone and sex-hormone-binding globulin in massively obese men.J Clin Endocrinol Metab. 1977; 45: 1211-1219
- Sex-hormone-binding globulin.Clin Endocrinol. 1974; 3: 69-96
- Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.Diabetes. 1973; 22: 507-513
- Hyperestrogenemia, diet, and disorders of Western societies.Am J Med. 1985; 78: 363-366
- Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels.Arteriosclerosis. 1988; 8: 227-236
- Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.N Engl J Med. 1989; 320: 702-706
- Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction.Am J Med. 1984; 76: 1041-1048
- Oestradiol levels in diabetic men with and without a previous myocardial infarction.Q J Med. 1987; 64: 617-623
- Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.Artery. 1983; 12: 1-23
- High and low density lipoprotein cholesterols in adolescent boys: Relationships with endogenous testosterone, estradiol, and Quetelet index.Metabolism. 1983; 32: 262-271
- Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol.Am J Med. 1985; 78: 23-27
- Sex hormones and lipoproteins in men.Am J Med. 1989; 87: 35-39
- Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis.Cardiology. 1982; 69: 98-103
- Sex steroid hormones are altered in essential hypertension.J Hypertens. 1989; 7: 181-187
- Relationship of plasma sex hormones to different parameters of obesity in male subjects.Metabolism. 1980; 29: 1041-1045
- Coronary risk factors and plasma sex hormones.Am J Med. 1982; 73: 648-651
- Serum estradiol levels in male smokers.Am J Med. 1984; 77: 858-862
- Cigarette smoking and increased endogenous estrogen levels in men.Am J Epidemiol. 1987; 126: 187-192
- Androgen plasma levels in male diabetics.J Endocrinol Invest. 1984; 7: 21-24
- Endogenous sex hormone levels in older adult men with diabetes mellitus.Am J Epidemiol. 1990; 132: 895-901
- Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions.Am J Cardiol. 1981; 48: 897-902
- Relationship between sex hormones and haemostatic factors in healthy middle-aged men.Atherosclerosis. 1988; 71: 71-76
- Sex hormones and high density lipoproteins in healthy males.Atherosclerosis. 1979; 34: 431-436
- Associations between sex hormones, thyroid hormones and lipoproteins.Clin Sci. 1981; 61: 649-651
- Blood pressure and endogenous testosterone in men: An inverse relationship.J Hypertens. 1988; 6: 329-332
- Plasminogen activator inhibitor in plasma is related to testosterone in men.Metabolism. 1989; 38: 1010-1015
- Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.J Clin Invest. 1983; 72: 1150-1172
- Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.Lancet. 1985; 1: 1242-1244
- Insulin and atheroma—An update.Lancet. 1987; 1: 1077-1079
- Effects of diabetes mellitus on cholesterol metabolism in man.N Engl J Med. 1977; 296: 1365-1371
- Changes in high density lipoprotein cholesterol after initiation of insulin therapy in non-insulin dependent diabetes mellitus: Relationship to changes in body weight.Am J Med Sci. 1983; 285: 14-20
- The effect of intravenous insulin on the circulatory responses to tilting in normal and diabetic subjects with special reference to baroceptor reflex block and atypical hypoglycaemic reactions.Clin Sci. 1968; 34: 419-430
- Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.JAMA. 1978; 240: 37-42
- Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids.J Clin Endocrinol Metab. 1987; 64: 960-963
- The effect of testosterone on the carbohydrate metabolism in normal subjects.Arch Int Pharmacodyn Ther. 1957; 111: 216-226
- Hyperinsulinemia and hyperandrogenemia: In vivo androgen response to insulin infusion.Obstet Gynecol. 1987; 69: 921-925
- Plasma testosterone and androstenedione in insulin dependent patients at time of diagnosis and during the first year of insulin treatment.Acta Endocrinol. 1982; 100: 406-409
- Glucose tolerance and smoking: A population study of oral and intravenous glucose tolerance tests in middle-aged men.Diabetologia. 1983; 25: 86-88
Article info
Publication history
Accepted:
April 27,
1992
Received:
October 11,
1991
Footnotes
☆Supported in part by the Myron C. Patterson, M.D., Fund.
Identification
Copyright
© 1993 Published by Elsevier Inc.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
